These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37616532)

  • 1. Current issues with procollagen III N-terminal peptide assay performance relevant to 2016 British Association for Dermatologist methotrexate-monitoring guidance.
    Taylor DR; Stone C
    Clin Exp Dermatol; 2023 Nov; 48(12):1378-1379. PubMed ID: 37616532
    [No Abstract]   [Full Text] [Related]  

  • 2. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists.
    Gyulai R; Bagot M; Griffiths CEM; Luger T; Naldi L; Paul C; Puig L; Kemény L
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):224-231. PubMed ID: 24731093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for psoriasis: current European practice. A postal survey.
    Boffa MJ
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
    Barker J; Horn EJ; Lebwohl M; Warren RB; Nast A; Rosenberg W; Smith C;
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):758-64. PubMed ID: 21198946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H; Aslam HM; Bjerring P; Søgaard H; Zachariae E; Heickendorff L
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate: prescribing and monitoring practices among the consultant membership of the British Association of Dermatologists.
    Collin B; Srinathan SK; Finch TM
    Br J Dermatol; 2008 Apr; 158(4):793-800. PubMed ID: 18241256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
    Kanzler MH; Gorsulowsky D
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):509. PubMed ID: 1564165
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
    Khan S; Subedi D; Chowdhury MM
    Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ; Kirby B; Smith A; Burrows P; Little R; Horan M; Hextall JM; Smith CH; Klaber M; Rogers S
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.
    van den Reek JMPA; Menting SP; Janssen WWL; Dhaliwal R; Heijboer AC; van Herwaarden AE; Sweep FCGJ; de Jong LM; Tjwa ET; Otero ME; Spuls PI; de Jong EMGJ
    Br J Dermatol; 2017 Nov; 177(5):1454-1457. PubMed ID: 28112796
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK; Rowland PL; Mitchell DM; Smith A; Chalmers RJ; Rowan B; Haboubi NY
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H; Heickendorff L; Søgaard H
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H; Søgaard H; Heickendorff L
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic chemotherapy for psoriasis: a national survey.
    Bergstresser PR; Schreiber SH; Weinstein GD
    Arch Dermatol; 1976 Jul; 112(7):977-81. PubMed ID: 947151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
    Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
    PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA and methotrexate therapy of psoriasis: how closely do dermatology departments follow treatment guidelines? Psoriasis Audit Workgroup of the British Association of Dermatologists.
    Bilsland DJ; Rhodes LE; Zaki I; Wilkinson SM; McKenna KE; Handfield-Jones SE; Williams RE
    Br J Dermatol; 1994 Aug; 131(2):220-5. PubMed ID: 7917986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.